China Pharma Holdings, Inc. CPHI
Set alert
At close · Oct 30
After hours · Oct 30, 7:58 PM ET
- YTD
- -48.36%
- 1 year
- -63.88%
- Open
- 0.65
- Prev close
- 0.65
- Mkt cap
- 26.88M
- Vol
- 184.28K
- Avg vol
- 1.90M
- EPS
- -0.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.6065
- High
- 0.6748
- Forward P/E
- 0.00
- Beta
- 0.71
- Short ratio
- 0.22
- Inst. own
- 0.21%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.214
- 200-d avg
- 0.2588
- 1y target
- 0.00
2Y chart
Events in this range
- Nov 13, 2024Earnings: -0.06; estimate 0; surprise —%
- Apr 15, 2025Split: 1 for 10
Signals (93)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| RSI: Overbought | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| RSI: Overbought | May 12, 2026 | 5 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| SMA: Bearish | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| RSI: Oversold | Feb 2, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 11, 2025 | 10 months ago |
| SMA: Bearish | Dec 10, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Dec 4, 2025 | 11 months ago |
| SMA: Bullish | Dec 2, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 20, 2025 | 11 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| SMA: Bearish | Oct 22, 2025 | 1 year ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| SMA: Bullish | Oct 7, 2025 | 1 year ago |
| SMA: Bearish | Oct 3, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 30, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 26, 2025 | 1 year ago |
| RSI: Overbought | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 17, 2025 | 1 year ago |
| RSI: Overbought | Sep 17, 2025 | 1 year ago |
| RSI: Overbought | Sep 11, 2025 | 1 year ago |
| SMA: Bullish | Sep 5, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| RSI: Oversold | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 24, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| SMA: Bullish | Jul 11, 2025 | 1 year ago |
| SMA: Bearish | Jun 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 17, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 9, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| RSI: Oversold | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 27, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 12, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 5, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 29, 2025 | 1 year ago |
| SMA: Bullish | Jan 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 15, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 14, 2025 | 1 year ago |
| RSI: Overbought | Jan 6, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 24, 2024 | 1 year ago |
| RSI: Oversold | Dec 13, 2024 | 1 year ago |
Key statistics
- Market cap
- 3.47M
- Enterprise value
- 6.68M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.55
- Price / book
- 0.26
- EPS (TTM)
- -0.25
- Beta
- 0.71
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -70.48%
- Revenue (TTM)
- 6.25M
- Revenue growth
- -15.80%
- Free cash flow
- 669.60K
- Total cash
- 739.34K
- Total debt
- 4.06M
- Return on equity
- -74.89%
- Shares outstanding
- 19.25M
- Short % of float
- 1.22%
- 50-day average
- 0.214
- 200-day average
- 0.2588
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.06 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.09 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -0.07 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.30 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.30 | — | — |
| May 12, 2023 | Mar 1, 2023 | 0.00 | -0.30 | — | — |
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- China
- Website
- chinapharmaholdings.com
News
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Crude Oil Gains 2%; GE Vernova Shares Fall After Q2 Earnings
- Nasdaq Down Over 100 Points; AT&T Shares Gain After Upbeat Earnings
- China Pharma Prices Registered Direct Offering Of 2.5M Shares At $2.00 Per Share
- Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- Why Super Micro Computer Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on CPHI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| LI ZHILIN | Chief Executive Officer | Stock Award(Grant) | Sep 28, 2023 | 15,138,100 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Xtx Topco Ltd | 0.11% | 21,587 | 3.88K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.10% | 19,047 | 3.43K | Sep 29, 2024 |
| First Community Trust Na | 0.00% | 30 | 5 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.04% | 14,500 | 2.61K | Jun 29, 2023 |